| Log in
Photo Credit: Reuters

Exclusive: India-China border tiff may derail $1.3 bn Fosun-Gland Pharma deal

21 July, 2017

The biggest ever Chinese acquisition on Indian soil may flounder as a border standoff between the two countries has cast a shadow over Shanghai Fosun Pharmaceutical Ltd’s propose ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Fosun completes revised deal for 74% stake in Gland Pharma

Fosun completes revised deal for 74% stake in Gland Pharma

Ranjani R 2 months ago
Fosun extends deadline to buy Gland Pharma but final hurdle remains

Fosun extends deadline to buy Gland Pharma but final hurdle remains

Ranjani R 4 months ago
China’s Shanghai Fosun Pharmaceutical (Group) Co. Ltd has extended the...
FIPB clears Fosun-Gland Pharma deal

FIPB clears Fosun-Gland Pharma deal

Ranjani R 8 months ago
Shanghai Fosun Pharmaceuticals (Group) Co. Ltd has received approval from...
No Comments

Exclusive: India-China border tiff may derail $1.3 bn Fosun-Gland Pharma deal

Powered by WordPress.com VIP